Inherited microcytic anemias due to disorders of iron and heme metabolism: An updated clinical review
Open Access
- 16 September 2026
- journal article
- review article
- Published by Wiley in HemaSphere
- Vol. 10 (9) , e70465
Abstract
Microcytic anemia is among the most common hematological abnormalities in clinical practice and is usually attributable to iron deficiency, thalassemia traits, or anemia of inflammation. A small but clinically important subset of patients, however, has inherited disorders of iron metabolism or heme synthesis presenting with persistent, unexplained, familial, or iron‐refractory microcytosis. Over the past decade, advances in the understanding of the hepcidin–ferroportin axis, erythroid iron regulation, standardized hepcidin assays, and next‐generation sequencing have substantially refined diagnosis, while expert guidance for iron‐refractory iron deficiency anemia (IRIDA) has refined management, and hepcidin‐targeted therapies in early development signal a shift towards mechanism‐based treatment, though their role in IRIDA remains investigational. This review provides an updated, clinically oriented framework for inherited microcytic anemias caused by defects in systemic iron homeostasis, cellular iron transport, mitochondrial iron utilization, and heme biosynthesis. We propose a contemporary diagnostic algorithm integrating clinical features, iron biomarkers, hepcidin assessment, and molecular testing, and review current and emerging therapeutic strategies. Early recognition enables accurate diagnosis, avoids inappropriate investigations and treatment, facilitates genetic counselling, and helps prevent irreversible organ damage, particularly in iron‐overload disorders.Keywords
This publication has 81 references indexed in Scilit:
- Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patientsAnnals of Hematology, 2024
- A Novel Homozygous Germline Mutation in Transferrin Receptor 1 (TfR1) Leads to Combined Immunodeficiency and Provides New Insights into Iron-Immunity AxisJournal of Clinical Immunology, 2024
- SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literatureHuman Mutation, 2021
- Intravenous Iron-Induced Hypophosphatemia: An Emerging SyndromeAdvances in Therapy, 2021
- Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight PatientsJournal of Clinical Immunology, 2020
- Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38Pediatric Blood & Cancer, 2020
- Standardized serum hepcidin values in Dutch children: Set point relative to body iron changes during childhoodPediatric Blood & Cancer, 2019
- Multi‐gene panel testing improves diagnosis and management of patients with hereditary anemiasAmerican Journal of Hematology, 2018
- Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractoryAmerican Journal of Hematology, 2016
- Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutationsHuman Mutation, 2011